Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Completed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: Vaccines may help the body build an effective immune response to kill cytomegalovirus infections. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients who have undergone a donor stem cell transplant and have cytomegalovirus infection that has not responded to therapy.

Key facts

Study ID

NCT00509691

Run by

University of Louisville

People needed

20

Starts

2007-06-01

Expected to finish

2011-12-01

Last updated by the study team

2017-05-09

Who can join

Age: 2 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.